The Zenith Drugs IPO date has been confirmed from February 19, 2024 and closes on February 22, 2024. Read the post to learn about Zenith Drugs IPO GMP.
Zenith medicines Developers IPO is a fixed price issue of Rs 40.68 crores. The price band is set at ₹ 75 to ₹ 79 per share. The minimal lot size for an operation is 1600 Shares. The minimal quantum of investment needed by retail investors is ₹ 126,400. The minimal lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹ 252,800.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of Zenith Drugs IPO:
Bidding Dates
Feb 19-22
Price Range
₹75 to ₹79 per share
Face Value
₹10 per share
GMP
₹35
Zenith Drugs IPO GMP
The Zenith Drugs IPO GMP Today is ₹35.
Zenith Drugs IPO Overview
The company Zenith Pharmaceuticals is launching a book- erected original public immolation (IPO) which is estimated at Rs 40.86 crores. 51. presently, the total number of shares issued and outstanding in this new share issue altogether stands at 49 lakh. Zenith medicines ’ partake public immolation (IPO) will run from February 19, 2024, and it’ll be closed on February 22, 2024. The Ideal time for cutting the Zadara medicinals IPO share allotment is on Friday 23 February 2024. The Zenith medicines ’ NSE SME original public immolation (IPO) date of Tuesday, February 27, 2024 originally listed to be blazoned.
The range of IPO price per share for Zenith medicines constitutes ₹ 75 – ₹ 79. The Zenith medicines IPO GMP Today is ₹ 35. still, the sale won’t do, If a minimum of 1600 share operation lot size isn’t met. Start investing from as low as ₹ 126,400 but you’re a small investor. Can start investing with as low as 2 lots of shares (coming to ₹ 252,800).
Zenith Drugs IPO Details
| IPO Date | February 19, 2024 to February 22, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹75 to ₹79 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 5,148,800 shares (aggregating up to ₹40.68 Cr) |
| Fresh Issue | 5,148,800 shares (aggregating up to ₹40.68 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 12,000,000 |
| Share holding post issue | 17,148,800 |
| Market Maker portion | 852,800 shares |
Zenith Drugs Limited Financial Information
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 11,249.04 | 9,793.83 | 6,858.47 |
| Revenue | 6,948.43 | 11,569.65 | 9,266.63 |
| Profit After Tax | 539.38 | 515.29 | 312.86 |
| Net Worth | 2,264.96 | 1,724.42 | 1,209.09 |
| Reserves and Surplus | 1,064.96 | 1,684.42 | 1,169.09 |
| Total Borrowing | 2,902.81 | 2,605.03 | 1,880.86 |
| Amount in ₹ Lakhs | |||
Zenith Drugs IPO Timeline
| IPO Open Date | Monday, February 19, 2024 |
| IPO Close Date | Thursday, February 22, 2024 |
| Basis of Allotment | Friday, February 23, 2024 |
| Initiation of Refunds | Monday, February 26, 2024 |
| Credit of Shares to Demat | Monday, February 26, 2024 |
| Listing Date | Tuesday, February 27, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 22, 2024 |
Company Profile
Zenith medicines Limited is a pharmaceutical company that was established in 2000 and specializes in producing and distributing affordable, high- quality specifics, including generics. As substantiation of its commitment to quality, the company complies with WHO-GMP regulations and has earned ISO 90012015 instrument from a recognised EuroUK instrument body. Over 600 products have entered blessing from the Food and Drug Administration; 325 of those are presently being produced. At Village Muradpura, Depalpur, Indore, the company is presently setting up a new product installation.
State of Madhya Pradesh. The company trades in the following regions: Southeast Asia’s Cambodia; Tajikistan; Liberia; Sierra Leone; Conakry; Malawi; Mauritius; Mozambique; Sudan; Tanzania; Bhutan; and Costa Rica. Specialized in third- party manufacturing, also known as white marker manufacturing, Zenith medicines Limited serves a number of high- profile medicinal companies, including Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma. There are 89 workers as of March 31, 2023, of whom 61 are paid on a payment base and 28 work under contract.
Registrar Info
| Name | Bigshare Services Pvt Ltd |
| Phone number | +91-22-6263 8200 |
| Email ID | [email protected] |
| Website | ipo.bigshareonline.com |
Contact Details
| Name | Zenith Drugs Limited |
| Phone number | +91 8435501867 |
| Email ID | [email protected] |
| Website | zenithdrugs.com |
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Zenith Drugs IPO FAQs
When Zenith Drugs IPO will open?
The Zenith Drugs IPO opens on February 19, 2024 and closes on February 22, 2024.
What is the lot size of Zenith Drugs IPO?
Zenith Drugs IPO lot size is 1600 Shares, and the minimum amount required is ₹126,400.
When is Zenith Drugs IPO allotment?
The finalization of Basis of Allotment for Zenith Drugs IPO will be done on Friday, February 23, 2024, and the allotted shares will be credited to your demat account by Monday, February 26, 2024.
When is Zenith Drugs IPO listing date?
The Zenith Drugs IPO listing date is not yet announced. The tentative date of Zenith Drugs IPO listing is Tuesday, February 27, 2024.
Leave a Reply